NCT01357603View on ClinicalTrials.gov

Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM

PHASE1CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2012

Conditions
Type1 Diabetes
Interventions
BIOLOGICAL

Glargine

dosage form: Subcutaneous injection

Trial Locations (1)

91911

Profil Institute for clinical Research, Chula Vista

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY

NCT01357603 - Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM | Biotech Hunter | Biotech Hunter